FDA Pulls Abbott’s Cylert From Market Due To Liver Toxicity
This article was originally published in The Pink Sheet Daily
Executive Summary
The ADHD drug will no longer be available after current supplies of pemoline generics are exhausted. Abbott stopped marketing the drug in May, citing low sales.